REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Celgene Corp (NQ: CELG)
122.58 USD  -1.06 (-0.86%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Celgene Corp
 
< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Investing in Cancer Research Is Worth the Risk: Echo He
May 23, 2013
Source: George S. Mack of The Life Sciences Report (5/23/13) http://www.thelifesciencesreport.com/pub/na/15301 If investigators could find a way to make breast cancer survivors truly cancer free, and... Read More
category RHHBY , INFI , CELG , and 5 more.
from Bio-Wire.Com
Celgene (CELG) Granted FDA Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer
May 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8364371 for the full story. Read More
from StreetInsider.com News Articles
iShares Nasdaq Biotechnology Index Fund Experiences Big Outflow
May 22, 2013
Symbols mentioned in this story: IBB, REGN, AMGN, CELG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
Celgene Corporation (CELG) - Daily Trading Review
May 22, 2013
NEW YORK (AVAFIN) -- A total of 17 block trades were executed today, typically ... Read More
from AVAFIN
Today’s Research on CELG, ARNA, INCY, SPPI, and GERN
May 21, 2013
from ACCESSWIRE
Options Players Wage on Celgene Corporation
May 16, 2013
NEW YORK (AVAFIN) -- Celgene Corporation witnessed a record number of call and put ... Read More
from AVAFIN
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter
May 15, 2013
Below are the top biotechnology stocks on the NASDAQ in terms of earnings estimate for the next quarter. Biogen Idec (NASDAQ: BIIB ) is estimated to post earnings of $2.07 per share in the September... Read More
category Benzinga , Highest EPS Estimates , CELG , and 6 more.
from Latest Articles from Benzinga.com
Jim Cramer's 5 Investing Sweet Spots
May 14, 2013
Jim Cramer often advocates themes in the market. These are big picture ideas that he believes will lift the fortunes of companies and by proxy their stocks. Following are 5 themes that he likes right... Read More
category Regeneron Pharmaceuticals Inc , EOG Resources Inc , ENSCO International Incorporated , and 14 more.
from CNBC.com News
Gene Therapy Company Bluebirdbio (BLUE) Files $86M IPO
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8338375 for the full story. Read More
from StreetInsider.com News Articles
Short Interest in Vertex Rises, in Celgene Falls
May 11, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the latter two weeks of April. The number of shares sold short in Dendreon (NASDAQ: DNDN ), Gilead Sciences... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 35 more.
from Latest Articles from Benzinga.com
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks... Read More
category Benzinga , ETFs , PJP , and 22 more.
from Latest Articles from Benzinga.com
Why I stopped using stop loss orders
May 09, 2013
A big problem with stop losses is that you give up control of your sell order. During volatile markets, that can cost you money. But there is an alternative, writes Michael Sincere. Read More
category VRX , Opinion , Commentary , and 12 more.
from MarketWatch
Celgene’s Revlimid Approaches FDA Decision For MCL Indication
May 07, 2013
Celgene Corporation (NASDAQ: CELG) remains just under its 52-week high of $128.52 per share as the market continues to reflect the company’s financial and developmental success halfway throughout the... Read More
category CELG , Bio/Wire
from Bio-Wire.Com
UPDATE: Celgene's Says Apremilast Achieves Statistical Significant for Primary, Major Secondary Endpoints in Fourth Pivotal Phase III Study
May 06, 2013
Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG ) today announced that statistical significance was achieved for the primary endpoint of ACR 20 at week 16 for patients... Read More
category Benzinga , CELG , News , and 1 more.
from Latest Articles from Benzinga.com
Celgene (CELG) Unit Achieves Statistical Significance in PALACE 4
May 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8308093 for the full story. Read More
from StreetInsider.com News Articles
Bio-Wire Weekly: April 29 – May 3rd, 2013
May 06, 2013
Bio-Wire Weekly: April 29 – May 3rd, 2013 To get this email earlier, sign up for our email list The Newsmakers: 1.) Auxilium Pharmaceuticals (NASDAQ: AUXL) Auxilium Pharma was down about 8% in the last... Read More
category Prime Content , AEGR , REGN , and 5 more.
from Bio-Wire.Com
IBB, AMGN, CELG, ALXN: ETF Inflow Alert
May 06, 2013
Symbols mentioned in this story: IBB, AMGN, CELG, ALXN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
Minyanville's T3 Morning Market Call: Time to Take Profits or Stay the Course?
May 06, 2013
Banks have been a bit lethargic while tech continues to be filled with opportunity. Read More
category MSFT , CELG , NFLX , and 1 more.
from Minyanville Headlines
Concert Pharma Reports Strategic Collaboration with Celgene
May 06, 2013
Concert Pharmaceuticals, Inc. today announced that it has entered into a strategic collaboration with Celgene Corporation (NASDAQ: CELG ) directed towards deuterium-modified compounds targeting cancer... Read More
category Benzinga , CELG , News
from Latest Articles from Benzinga.com
Top Fund Buys Focus On Defensive Stocks, Housing
May 02, 2013
April notched another month of gains for the stock market. That's four straight months so far this year. But this market rally is getting long in the tooth and top fund managers have been cautious in... Read More
category Mutual Funds
from Investor's Business Daily - Investing RSS
Illumina and Other Bargain Biotech Stocks Worth a Look Now
May 01, 2013
The research team at PropThink, which focuses on emerging growth companies in the health care sector, recently offered a list of bargain biotech stocks worth a look. The stocks that made the list... Read More
category SHPG , amgen , Benzinga , and 31 more.
from Latest Articles from Benzinga.com
Uptrend Call Working As Celgene Stock Rises 51.6% (CELG)
April 30, 2013
from Comtex SmarTrend® News Briefs
Jefferies Boosts Celgene (CELG) PT to $152 on Upcoming MM-020 Data
April 30, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8288094 for the full story. Read More
from StreetInsider.com News Articles
Best-Selling Novels The Critics Hated
April 29, 2013
category NYSE:D , NASDAQ:GOOG , NASDAQ:CELG , and 2 more.
from Forbes Real Time
Don't Sell In May And Go Away From Stocks Like These
April 29, 2013
By Rocky White Read More
category NYSE:D , NASDAQ:GOOG , NASDAQ:CELG , and 2 more.
from Forbes Real Time
FORMA Therapeutics, Celgene (CELG) Enter Protein Homeostasis Collaboration
April 29, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8284229 for the full story. Read More
from StreetInsider.com News Articles
Bio-Wire Weekly: April 22 – April 26, 2013
April 29, 2013
Bio-Wire Weekly: April 22 – April 26, 2013 Good morning. Please sit, have a cup of coffee (or tea), and let’s go over last week’s action in the biotech & small pharma sector Note: get the weekly... Read More
category THRX , SRPT , CELG , and 9 more.
from Bio-Wire.Com
Lightning Round: Celgene, Dell & More
April 26, 2013
Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites. Read More
category General Electric , Lightning Round , Deere & Co , and 10 more.
from CNBC.com News
Short Sellers Move into Celgene, Regeneron
April 26, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Amgen... Read More
category Regeneron Pharmaceuticals , amgen , Benzinga , and 34 more.
from Latest Articles from Benzinga.com
IBB, CELG, BIIB, ALXN: Large Inflows Detected at ETF
April 26, 2013
Symbols mentioned in this story: IBB, CELG, BIIB, ALXN Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... Read More
category ETFs
from ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here